关于我们
350 million patients globally have rare genetic diseases, including 3.5 million in the UK. Leukodystrophies are devastating rare diseases with limited treatment and research on leukodystrophy is under-represented in the UK. A more collaborative and united approach in leukodystrophy research will bring together our national experts and allow rapid and efficient progress towards therapeutic interventions. O U R G O A L S: To unite researchers and clinicians working on leukodystrophies, promote collaborative projects and develop therapies.
- 网站
-
www.leukolabs.org
LEUKOLABS的外部链接
- 所属行业
- 非盈利组织
- 规模
- 2-10 人
- 类型
- 合营企业
- 创立
- 2022
- 领域
- leukodystrophy和network